MiReven Announces Positive In Vitro Results for miRNA-7-5p in Melanoma

Publication in Biochemical and Biophysical Research Communications shows miRNA-7-5p inhibits melanoma cell migration and invasion MiReven launches its new website at www.mireven.com.au   Perth, Western Australia, February 12, 2013 – MiReven, an Australian microRNA company commercialising discoveries from the Western Australian Institute for Medical Research (WAIMR) on the anti-cancer potential of miR-7, today announced the publication […]